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Background: Familial Mediterranean fever (FMF) is known the most com-
mon monogenic autoinflammatory disease. Its prevalence is reported high
from the eastern Mediterranean areas (1) The disease is characterized
by episodes of fever, serositis, arthritis,renal complications and other dif-
ferent clinical manifestations (2)
Objectives: Here, we aimed to present our data of our 139 FMF patients
for demonstrating the demographic and clinical features of the study
group,from North-western part of Turkey.
Methods: A total of 139 FMF patients who were diagnosed and treated
in the department of Internal medicine/Rheumatology, Sakarya University
(North-western area of Turkey) were included in the study and the demo-
graphic and clinical characteristics of the patients were examined.
Results: The mean age of the patients was 39.02 ± 11.3. Male gender
was 42 (30.2%) and female gender was 97 (69.8%).107 (77%) of
patients had fever and 32 (23%) had no history of fever. 127 (91.4%)
patients complained about peritonitis, 27 (%19.4) patients had pleuritic
pain, 19 (13.7%) patients had erysipelas like erythema and 53 (38.1%)
patients had arthritis attack. 34 (24.5%) patients also had sacroiliitis. The
ratio of resistance of treatment response to colchicine drugs that can be
available in Turkey (Colchicum dispert
®
), 6 (4.3%) was determined. Inter-
estingly these patients responded to the colchicine drugs available from





) None of our patients needed anti-IL1 therapies. The rate of
amyloidosis was 5 (3.6%).
Conclusion: FMF is a disease with high morbidity and mortality, 95.7%
of the patients in our region have response to colchicine drugs which is
available in our country. The remaining patients have also response to
colchicine available from some other countries. None of our patients had
anti-IL1 therapies.
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Background: Deficiency of adenosine deaminase 2 (DADA2) is a recently
identified disease caused by mutations in the CECR1/ADA2 gene, encod-
ing for adenosine deaminase 2 protein. Clinical presentation is variable
and includes early-onset polyarteritis nodosa, hemorrhagic and ischemic
strokes, hypogammaglobulinemia and cytopenia
Objectives: To present the clinical cases of two Brazilian siblings with
early stroke episodes carrying a homozygous CECR1/ADA2 mutation.
Methods: Chart review of clinical data, laboratory tests and mutation
analysis
Results: The index case is a 7-year-old boy who presented to the emer-
gency unit with right lower limb weakness, rhyme deviation and palpebral
ptosis, associated with recurrent and intermittent fever, mood change and
hypertension. The physical exam revealed drowsiness, lateral and vertical
ocular paresis, diplopia, facial palsy, and bilateral ataxia. The brain MRI
showed acute left mesencephalic small vessel lacunar stroke, previous
right mesencephalic subacute stroke, and cerebellar cavity related with
anterior cerebellar artery segmental narrowing. Laboratory tests revealed
increased inflammatory markers and anemia. Autoantibodies and viral
screening were negative. Renal ultrasound showed a pattern of low
resistance in the intrarenal arteries bilaterally. At this time, he was diag-
nosed as polyarteritis nodosa (PAN). Despite of adequate treatment
(cyclosphosphamide and corticosteroids), two new stroke episode occurred
at left head of caudate and right thalamus. His brother, a 9-year-old
healthy boy at that time, had a previous history of ischemic stroke when
he was 4 years old, after receiving a vaccine, with complete recover.
Considering this family history and the fact that parents are consanguine-
ous, mutation analysis of CECR1/ADA2 gene was performed and showed
homozygosity for the p.Y453C mutation in exon 9 in both siblings and
heterozygosity for the same mutation in both parents. Although the eldest
boy remained asymptomatic for 5 years without any specific treatment,
shortly after the identification of the gene mutation, he presented recur-
rent fever episodes, myalgia, livedo reticularis and increased inflammatory
markers. Anti-TNF treatment was initiated for both patients with good dis-
ease control.
Conclusion: DADA2 should be suspected in patients with PAN-like phe-
notype and history suggestive of an inherited disease (eg.: affected sib-
lings and consanguineous parents) or resistance to conventional
treatment.
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Background: Behçet’s disease is a chronic, recurrent and systemic vas-
culitis that may affect veins and arteries at all diameters. Small vessel
involvement is responsible for most of its pathological signs.
Objectives: We aimed to compare the nailfold capillaroscopy findings of
patients with Behçet’s disease to a healthy control group and examine
the relationships, as well as revealing the relationships with the sub-type,
activity and other characteristics of Behçet’s disease.
Methods: We conducted a cross-sectional analysis of 153 patients with
Behçet’s disease and 165 healthy volunteers in a single center. The
capillaroscopic findings of the 2nd-5th fingers of both hands of the partic-
ipants in the Behçet’s patients and control groups were included in the
analysis. Capillaroscopic findings were evaluated by two different experts
who were experienced in this field by using the scoring at Atlas of Capil-
laroscopy in Rheumatic diseases by Maurizio Cutolo (1).
Results: There was no statistically significant difference between the two
groups in terms of age or sex (respectively p=0.189 and p=0.585). There
was no difference between the Behçet’s patients and healthy volunteers
in the qualitative analysis on capillary density, capillary visibility, aneurism,
capillary tortuosity, capillary enlargement and presence of avascular areas
(p values respectively: 0.610, 0.147, 0.481, 0.057, 0.514 and 0.110). In
the Behçet’s patients, bushy capillaries (24.2%, 37/153), capillary dilatation
(32%, 49/153) and microhemorrhage (39.2%, (60/153) rates were signifi-
cantly higher than those in the healthy control group (p<0.001). In the
quantitative analysis, total capillaroscopy score was significantly higher in
the Behçet’s patients than those in the healthy control group (p<0.001)
(Table 1). No statistically significant relationship was found between the
presence of clinical signs and capillaroscopy scores, except for erythema
nodosum.
Conclusion: the Behçet’s patients had significantly higher total capillaro-
scopy scores in comparison to those in the healthy control group. Based
on these data, we believe that the capillaroscopic changes found in Beh-
çet’s patients, though unspecific, may support clinical diagnosis in uncer-
tain cases where Behçet’s disease is considered as a probability. There
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